Treace Medical Concepts, Inc. (TMCI)
TMCI moved a median of +0.10% 30 minutes after news, and +0.17% by the close. How TMCI actually reacts to news — the realized, point-in-time move the market made, measured across 1,137 labeled events over the last three years with zero look-ahead.
TMCI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.08% | 52% | 1,127 |
| 30-min | +0.10% | 52% | 1,136 |
| 60-min | 0.00% | 48% | 1,136 |
| to close | +0.17% | 53% | 1,132 |
| Middle 50% of TMCI reactions | -0.80% to +0.84% |
|---|---|
| Median reaction (30-min) | +0.10% |
| Measured reactions | 1,137 |
Half of all Treace Medical Concepts, Inc. news events land between -0.80% and +0.84% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How TMCI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 28 | -1.78% | 14% | -7.33% |
| Rating reiterations | 34 | -0.42% | 38% | -0.97% |
| Price-target raises | 10 | -0.12% | 50% | -0.28% |
| Price-target cuts | 13 | 0.00% | 46% | -2.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how TMCI ranks against every other measured name →
That’s how TMCI usually reacts — get an email when it moves on news →Email me when TMCI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TMCI's baseline. Nothing else.
Recent TMCI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -1.11% | -0.22% | |
| Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure | Press release | GlobeNewswire | +1.64% | -1.75% | |
| Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting | Press release | GlobeNewswire | -1.09% | -0.22% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -9.07% | -6.11% | |
| Form 8-K TREACE MEDICAL CONCEPTS, For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | -9.07% | -6.11% | |
| Treace Medical Concepts Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | -9.07% | -6.11% | |
| Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | +0.00% | +0.63% | |
| Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 | Press release | GlobeNewswire | +0.00% | -2.44% | |
| Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System | Press release | GlobeNewswire | +3.15% | +1.45% | |
| Treace to Present at the Sidoti Small Cap Conference | Press release | GlobeNewswire | -3.30% | -4.25% | |
| Form 8-K TREACE MEDICAL CONCEPTS, For: May 19 | SEC filing · Form 8-K | SEC EDGAR | -2.30% | +0.35% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.79% | -4.74% | |
| Form 8-K TREACE MEDICAL CONCEPTS, For: May 08 | SEC filing · Form 8-K | SEC EDGAR | +3.79% | -4.74% | |
| Form S-8 TREACE MEDICAL CONCEPTS, | SEC filing · Form S-8 | SEC EDGAR | -4.50% | -3.96% | |
| Treace Medical Concepts Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +3.79% | -4.74% | |
| Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | Press release | GlobeNewswire | -0.55% | +9.39% | |
| Form 8-K TREACE MEDICAL CONCEPTS, For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | +2.56% | +11.68% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | +0.00% | |
| Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System | Press release | GlobeNewswire | +0.74% | -0.74% | |
| Form ARS TREACE MEDICAL CONCEPTS, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.69% | +0.00% | |
| Form DEF 14A TREACE MEDICAL CONCEPTS, For: Apr 03 | SEC filing · Form DEF | SEC EDGAR | +0.69% | +0.00% | |
| Form DEFA14A TREACE MEDICAL CONCEPTS, | SEC filing · Form DEFA14A | SEC EDGAR | +0.69% | +0.00% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | +1.75% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.40% | +7.63% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.81% | -2.44% | |
| Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.27% | +2.32% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.38% | -0.38% | |
| Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.68% | -1.02% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.07% | -4.05% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -1.08% | -2.53% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.99% | +17.02% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -1.76% | -2.11% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.00% | -1.57% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.82% | -9.29% | |
| Form 10-K TREACE MEDICAL CONCEPTS, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -2.10% | -13.08% | |
| Form 8-K TREACE MEDICAL CONCEPTS, For: Feb 27 | SEC filing · Form 8-K | SEC EDGAR | -2.10% | -13.08% | |
| Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results | Press release | GlobeNewswire | -2.10% | -13.08% | |
| Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference | Press release | GlobeNewswire | -0.50% | -1.99% | |
| Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.26% | +1.03% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | +2.13% | |
| Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.54% | -2.14% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.51% | -4.04% | |
| Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 | Press release | GlobeNewswire | +2.10% | -2.10% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.09% | -8.45% | |
| Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -3.52% | -2.64% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | -4.89% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.67% | -6.07% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.64% | -2.13% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.41% | +4.10% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.58% | -3.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TMCI section they belong to.
Where else TMCI is measured.
TMCI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Treace Medical Concepts, Inc.'s median reaction calculated?
Every labeled TMCI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,137 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of TMCI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TMCI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.